Block 2 Drugs Flashcards
Heparin
Anticoagulant
Binds reversibly to anti-thrombin III and enhances its inactivation of thrombin and FXa
- Unfractioned heparin: inhibits FXa and thrombin
- LMWH: Primarily inhibits FXa
Used for:
- Low dose: prophylaxis, prevention of VTE
- Treatment dose: prevents progression of existing clots
Warfarin
Anticoagulant
Affects vitamin K metabolism by inhibiting synthesis of vitamin K-dependent coagulation factors (VII, IX, X and prothrombin/FII) (1972)
Used for :
- Prophylaxis and treatment of VTE
- Prevention of ischaemic stroke in AF
Dabigatran
New Oral Anticoagulant (NOAC)
Competitive, reversible inhibitor of thrombin
B2-Adrenergic Agonists
- Salbutamol (Short acting)
- Terbutaline (Short acting)
- Salmeterol (Long acting)
- Formoterol (Long acting)
B2-Adrenergic Agonists:
MoA
Side Effects
Cellular target: Bronchiolar smooth muscle cells
Molecular target: Stimulation of B2-adrenergic receptors
- Activation of B2AR activates G-protein
- Increases activation of adenylate cyclase
- Adenylate cyclase converts ATP to cAMP
- Increased cAMP activates protein kinase A which:
- Drives Ca2+ into intracellular storage vesicles away from cytoplasm.
- Reduces activity of myosin light chain kinase = reduced muscle contraction
- Dephosphorylation of myosin light chain = reduced muscle contraction
- Reduced cytoplasmic Ca2+ levels reduce smooth muscle contraction resulting in bronchodilation.
Side effects:
- Tremor
- Tachycardia
- Cardiac arrhythmias
What is the difference in the MoA of short and long acting B2-Adrenergic Agonists?
Short acting: directly binds to activation site on B2-adrenergic receptor
Long acting:
- Formoterol: Binds to depot in lipid bilayer before binding to active site on B2AR
- Salmeterol: Membrane translocation for 30 mins before binding to active site.
Anti-cholinergics
Drugs
MoA
Side Effects
- Ipratropium (short acting)
- Tiotropium (long acting)
Blocks M3 muscarinic acetylcholine receptors preventing stimulating effects of ACh:
- Inhibits activation of G-protein therefore inhibits activation of phospholipase C enzyme (PLC)
- PLC therefore cannot release calcium from intracellular stores
- Cytoplasmic Ca2+ levels do not rise therefore bronchiolar smooth muscle contraction does not increase (inhibits bronchoconstriction)
- =Bronchiolar relaxation
Side Effects:
- Dry mouth
- Constipation
- Urinary retention
Methylxanthines
Drugs
MoA
Side Effects
- Theophylline
- Aminophylline
Inhibit phosphodiesterase enzymes (PDE) preventing it from inhibiting CAMP.
CAMP levels maintained therefore protein kinase A enzyme activated which stores intracellular Ca2+ into storage vesicles.
Reduced cytoplasmic Ca2+ results in less smooth muscle contraction so less bronchoconstriction
Side effects:
- Cardiac arrhythmias
- Seizures
Glucocorticoids
Drugs
MoA
Side Effects
- Beclomethasone
- Prednisolone
- Fluticasone
- Hydrocortisone
Targets immune cells of the lungs: macrophages, T-lymphocytes, eosinophils.
Activates glucocorticoid receptors which interact with selected nuclear DNA sequences and influences the expression of genes:
- Repression of pro-inflammatory mediators: IL-3, IL-5, Th2 cytokines
- Expression of anti-inflammatory products: secreted leukocyte peptidase inhibitor (SLPI), Lipcortin-1 and upregulation of B2 adrenoceptors.
Side Effects:
- Hyperglycaemia
- Muscle wasting
- Thinning skin
- Osteoporosis
- Increased risk of infection
- Moon face (facial swelling)
Leukotriene Receptor Antagonists:
Drugs
MoA
Side Effects
- Montekulast
- Zafirlukast
Leukotrienes released from mast cell upon activation, normally binds to CysLT1 leukotriene receptor to:
- Stimulate bronchiolar smooth muscle constriction
- Bind to and recruit immune cells such as eosinophils by guiding eosinophil chemotaxis.
Leukotriene receptor antagonists block CysLT1 receptors on smooth muscle and eosinophils blocking the above effects.
Used as preventer
Side Effects:
- Abdo pain
- Headaches
Beta-Adrenergic Receptor Antagonists
Drugs
MoA
Uses
Side Effects
- Bisoprolol
- Atenolol (B1 cardioselective)
- Propranolol (B1 and B2)
Competitive inhibitors of adrenaline and noradrenaline at beta-adrenergic receptors, inhibit sympathetic stimulation of heart muscle.(B1 antagonists selective for cardiomyocytes and contractility) by inhibiting cAMP cascade (PKA etc) which in cardiomyocytes drives contraction (opposite to bronchiolar smooth muscle)
- Negative inotropes and chronotropes.
- Reduce workload of the heart relieving oxygen demand. (reduced heart rate = reduced cardiomyocyte contractility)
Side Effects:
- Dizziness
- Constipation
Contraindicated in asthmatic patients
Calcium Channel Inhibitors:
Drugs
MoA
Side Effects
- Nifedipine
- Amlodipine
Prevent opening of L-type voltage-gated calcium channels reducing influx of Ca2+ into cells.
Reduces intracellular calcium has vasodilator effect on resistance vessels = reduced afterload. Causes dilation of coronary arteries increasing blood flow.
Do not act on veins.
Side Effects:
- Ankle swelling
- Palpitations
HMG-CoA Reductase Inhibitors:
Drugs
MoA
- Atorvastatin
- Simvastatin
Reduce cholesterol reducing risk of atherosclerosis
Inhibit HMG-CoA Reductase (HMGCR) enzyme which reduces circulating cholesterol by:
- Reducing intrinsic production of cholesterol
- Promote uptake of excess cholesterol by liver.
Uses:
- Treatment of HF without affecting BP
Nitrate Vasodilators
Drugs
MoA
Side Effects
- Glyceryl Trinitrate (GTN)
- Isosorbide Mononitrate (ISMN)
Metabolised to release NO which diffuses into cell and stimulates soluble guanylate cyclase.
Increases cGMP in vascular smooth muscle cells:
- Drives dephosphorylation of myosin light chains via activation of MLC phosphatase.
- Inhibits influx of Ca2+ into smooth muscle cytoplasm causing relaxation.
Works on vascular smooth muscle of arteries and veins:
- Venodilation: reduces cardiac preload (capacitance)
- Arteriodilation: coronary artery vasodilation increases blood flow to myocardium
- Moderate arteriolar dilation: reduces cardiac afterload
Side Effects:
- Headache
Anti-cholinergics for emergency treatment:
Drugs
MoA
Uses
- Atropine
Blockage of muscarinic M2 acetylcholine receptors on cardiomyocytes. Inhibits effects of parasympathetic, cholinergic vagus nerve transmission which normally exerts negative chronotropy. Increases heart rate by accelerating repolarisation rate in cardiac muscle.
Uses:
- Sinus bradycardia